Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Clin Chem Lab Med. 2020 Jul 28;58(8):1214–1222. doi: 10.1515/cclm-2019-1172

Table 3. Differences in achievement of MR4 in paired BM and PB samples of 134 CML patients in long-term follow-up.

≥12 months ≥MR4 PB
 Total, n
No, n Yes, n
BM No, n 164 (50.9%) 11 (3.4%) 175 (54.3%)
Yes, n 35 (10.9%) 112 (34.8%) 147 (45.7%)
p = 0.0007 Total, n 199 (61.8%) 123 (38.2%) 322 (100%)

Contingency table with McNemar test of samples from patients undergoing TKI treatment for ≥12 months. BM, bone marrow; CML, chronic myeloid leukemia; PB, peripheral blood.